2012
Epidemiology of Myelodysplastic Syndromes
Ma X. Epidemiology of Myelodysplastic Syndromes. The American Journal Of Medicine 2012, 125: s2-s5. PMID: 22735748, PMCID: PMC3394456, DOI: 10.1016/j.amjmed.2012.04.014.Peer-Reviewed Original ResearchConceptsMyelodysplastic syndromeIncidence of MDSBetter risk-stratify patientsClonal hematopoietic stem cell malignanciesHematopoietic stem cell malignanciesRisk-stratify patientsStem cell malignanciesMore effective treatmentsMDS prognosisDifferent comorbiditiesPrognostic factorsSignificant morbidityEtiologic factorsDisease burdenPoor survivalEffective treatmentCell malignanciesHigh mortalityNew casesHeterogeneous groupComorbiditiesSyndromeDiseaseRecent studiesPotential interactions
2007
Clustering in the incidence of myelodysplastic syndromes
Ma X, Selvin S, Raza A, Foti K, Mayne ST. Clustering in the incidence of myelodysplastic syndromes. Leukemia Research 2007, 31: 1683-1686. PMID: 17507092, DOI: 10.1016/j.leukres.2007.03.032.Peer-Reviewed Original ResearchConceptsIncidence of MDSMyelodysplastic syndromePopulation-based cancer registry dataEtiology of MDSPopulation-based dataCancer registry dataGroup of malignanciesPoor prognosisObscure etiologyPotential clusteringRegistry dataHigh incidenceEtiologic hypothesesLarger sample sizeIncidenceSyndromeP-valueEtiologyFuture studiesState of ConnecticutCensus tractsSample sizeIntriguing findingPrognosisMalignancy